vs
Side-by-side financial comparison of ARS Pharmaceuticals, Inc. (SPRY) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.
WIDEPOINT CORP is the larger business by last-quarter revenue ($42.3M vs $28.1M, roughly 1.5× ARS Pharmaceuticals, Inc.). WIDEPOINT CORP runs the higher net margin — -2.0% vs -147.1%, a 145.1% gap on every dollar of revenue. On growth, WIDEPOINT CORP posted the faster year-over-year revenue change (12.3% vs -67.6%).
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...
SPRY vs WYY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $28.1M | $42.3M |
| Net Profit | $-41.3M | $-849.4K |
| Gross Margin | — | 13.8% |
| Operating Margin | -147.6% | -1.9% |
| Net Margin | -147.1% | -2.0% |
| Revenue YoY | -67.6% | 12.3% |
| Net Profit YoY | -182.8% | -138.3% |
| EPS (diluted) | $-0.41 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $28.1M | $42.3M | ||
| Q3 25 | $32.5M | $36.1M | ||
| Q2 25 | $15.7M | $37.9M | ||
| Q1 25 | $8.0M | $34.2M | ||
| Q4 24 | $86.6M | $37.7M | ||
| Q3 24 | $2.1M | $34.6M | ||
| Q2 24 | $500.0K | $36.0M | ||
| Q1 24 | $0 | $34.2M |
| Q4 25 | $-41.3M | $-849.4K | ||
| Q3 25 | $-51.2M | $-559.2K | ||
| Q2 25 | $-44.9M | $-618.5K | ||
| Q1 25 | $-33.9M | $-724.1K | ||
| Q4 24 | $49.9M | $-356.4K | ||
| Q3 24 | $-19.1M | $-425.2K | ||
| Q2 24 | $-12.5M | $-499.6K | ||
| Q1 24 | $-10.3M | $-653.1K |
| Q4 25 | — | 13.8% | ||
| Q3 25 | — | 14.6% | ||
| Q2 25 | — | 13.5% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 12.6% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 13.6% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | -147.6% | -1.9% | ||
| Q3 25 | -163.7% | -1.3% | ||
| Q2 25 | -302.9% | -1.9% | ||
| Q1 25 | -466.3% | -2.4% | ||
| Q4 24 | 54.5% | -0.8% | ||
| Q3 24 | -1051.6% | -1.3% | ||
| Q2 24 | -3068.0% | -1.3% | ||
| Q1 24 | — | -1.9% |
| Q4 25 | -147.1% | -2.0% | ||
| Q3 25 | -157.4% | -1.5% | ||
| Q2 25 | -285.6% | -1.6% | ||
| Q1 25 | -425.7% | -2.1% | ||
| Q4 24 | 57.7% | -0.9% | ||
| Q3 24 | -925.0% | -1.2% | ||
| Q2 24 | -2503.2% | -1.4% | ||
| Q1 24 | — | -1.9% |
| Q4 25 | $-0.41 | $-0.08 | ||
| Q3 25 | $-0.52 | $-0.06 | ||
| Q2 25 | $-0.46 | $-0.06 | ||
| Q1 25 | $-0.35 | $-0.08 | ||
| Q4 24 | $0.52 | $-0.05 | ||
| Q3 24 | $-0.20 | $-0.04 | ||
| Q2 24 | $-0.13 | $-0.05 | ||
| Q1 24 | $-0.11 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.0M | $9.8M |
| Total DebtLower is stronger | $96.4M | — |
| Stockholders' EquityBook value | $114.3M | $11.5M |
| Total Assets | $327.7M | $79.8M |
| Debt / EquityLower = less leverage | 0.84× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $245.0M | $9.8M | ||
| Q3 25 | $288.2M | $12.1M | ||
| Q2 25 | $240.1M | $6.8M | ||
| Q1 25 | $275.7M | $3.7M | ||
| Q4 24 | $314.0M | $6.8M | ||
| Q3 24 | $204.6M | — | ||
| Q2 24 | $218.7M | — | ||
| Q1 24 | $223.6M | — |
| Q4 25 | $96.4M | — | ||
| Q3 25 | $96.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $114.3M | $11.5M | ||
| Q3 25 | $147.7M | $12.2M | ||
| Q2 25 | $192.3M | $12.6M | ||
| Q1 25 | $229.0M | $13.0M | ||
| Q4 24 | $256.8M | $13.6M | ||
| Q3 24 | $201.0M | $13.8M | ||
| Q2 24 | $215.2M | $14.0M | ||
| Q1 24 | $223.9M | $14.2M |
| Q4 25 | $327.7M | $79.8M | ||
| Q3 25 | $372.8M | $70.6M | ||
| Q2 25 | $313.5M | $76.6M | ||
| Q1 25 | $327.3M | $71.4M | ||
| Q4 24 | $351.2M | $71.6M | ||
| Q3 24 | $217.6M | $56.9M | ||
| Q2 24 | $222.0M | $58.6M | ||
| Q1 24 | $227.6M | $54.4M |
| Q4 25 | 0.84× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-43.5M | $-173.5K |
| Free Cash FlowOCF − Capex | — | $-270.0K |
| FCF MarginFCF / Revenue | — | -0.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-43.5M | $-173.5K | ||
| Q3 25 | $-47.0M | $5.9M | ||
| Q2 25 | $-39.6M | $3.2M | ||
| Q1 25 | $-40.7M | $-3.2M | ||
| Q4 24 | $42.0M | $2.4M | ||
| Q3 24 | $-14.5M | $1.9M | ||
| Q2 24 | $-7.3M | $-1.1M | ||
| Q1 24 | $-6.7M | $-1.6M |
| Q4 25 | — | $-270.0K | ||
| Q3 25 | $-47.2M | $5.9M | ||
| Q2 25 | $-39.6M | $3.1M | ||
| Q1 25 | $-40.8M | $-3.3M | ||
| Q4 24 | $41.7M | $2.4M | ||
| Q3 24 | $-14.6M | $1.8M | ||
| Q2 24 | $-7.3M | $-1.1M | ||
| Q1 24 | $-6.8M | $-1.6M |
| Q4 25 | — | -0.6% | ||
| Q3 25 | -145.4% | 16.4% | ||
| Q2 25 | -252.2% | 8.1% | ||
| Q1 25 | -512.1% | -9.5% | ||
| Q4 24 | 48.2% | 6.4% | ||
| Q3 24 | -706.3% | 5.3% | ||
| Q2 24 | -1463.4% | -3.0% | ||
| Q1 24 | — | -4.6% |
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.6% | 0.1% | ||
| Q2 25 | 0.3% | 0.2% | ||
| Q1 25 | 1.1% | 0.1% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 6.8% | 0.2% | ||
| Q2 24 | 7.6% | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
WYY
| Carrier Services | $26.8M | 63% |
| Managed Services | $15.5M | 37% |
